COPD Exacerbations, Air Pollutant Fluctuations, and Individual-Level Factors in the Pandemic Era.

Abstract

Purpose: Pandemic-era associations between air pollutant exposures and exacerbations of chronic obstructive pulmonary disease (COPD) are under-explored. Given the considerable observed pandemic-era pollutant fluctuations, these associations were investigated along with possible individual-level risk factors.

Patients and methods: Participants with spirometry-confirmed COPD from Canadian Cohort Obstructive Lung Disease (CanCOLD) were included, with data collected before ("pre-pandemic") and during ("pandemic") the COVID-19 pandemic. Nitrogen dioxide (NO₂), fine particulate matter (PM_2.5), ground-level ozone (O₃), total oxidant (O_x) and weather data were obtained from national databases. Associations between each air pollutant and "symptom-based" exacerbations (increased dyspnea or sputum volume/purulence ≥48hrs) and "event-based" exacerbations ("symptom-based" plus requiring antibiotics, corticosteroids, or unscheduled healthcare use) were estimated in separate models. Generalized estimating equations (GEE) models were reported as rate ratios (RRs) per interquartile range (IQR) increment in pollutant concentration with 95% confidence intervals (95% CIs).

Results: NO₂, PM_2.5, and O_x (NO₂+O₃) concentrations (but not O₃) fell significantly during the pandemic. In the 673 participants with COPD included, both symptom-based and event-based exacerbation rates were likewise significantly higher during the pre-pandemic period. During the pre-pandemic period, O_x was positively associated with symptom-based exacerbations (RR: 1.21 [1.08,1.36]). During the pandemic period, O_x was positively associated with symptom-based (1.46 [1.13,1.89]) and event-based (1.43 [1.00,2.05]) exacerbations. Fewer self-reported pandemic protective behaviors, and higher viral infectious symptoms, were also associated with exacerbations. In stepwise multivariable risk-factor analyses, female gender (1.23 [1.04,1.45] and 1.41 [1.13,1.76]) and co-morbid asthma (1.65 [1.34,2.03] and 1.54 [1.19,2.00]) were associated with symptom-based and event-based exacerbations, respectively, blood eosinophils (1.42 [1.10,1.84]) were associated with event-based exacerbations, and each IQR increment in O_x was associated with symptom-based exacerbations (1.31 [1.06,1.61]).

Conclusion: O_x exposure was consistently associated with symptom-based COPD exacerbations, and female gender, co-morbid asthma, and blood eosinophilia were found to be relevant risk factors.